Take a “Buyer Beware” Approach With Preliminary Data

May 2021

The ongoing race to prevent and treat COVID-19 is raising questions about “preprint” reports and other preliminary data.

Preprints are early versions of articles posted online BEFORE peer review or editing. “Early release” or “online first” articles are different...they go through full review before publication.

We know that peer review is a key step to evaluate if study methods and conclusions are appropriate...and to help keep weak or faulty data from being distributed. This limits misinformation.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote